Molecular Diagnostics: Assays, Tissues, Progress, and Pitfalls

This publication has 13 references indexed in Scilit:

• Thymidylate Synthase Expression in Hepatic Tumors Is a Predictor of Survival and Progression in Patients With Resectable Metastatic Colorectal Cancer
  Journal of Clinical Oncology, 2003
• Issues in clinical trial design for tumor marker studies
  Seminars in Oncology, 2002
• Thymidylate Synthase Expression in Colorectal Cancer: A Prognostic and Predictive Marker of Benefit From Adjuvant Fluorouracil-Based Chemotherapy
  Journal of Clinical Oncology, 2002
• Predictive value of thymidylate synthase expression in resected metastases of colorectal cancer
  European Journal Of Cancer, 2002
• A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil
  British Journal of Cancer, 2001
• Molecular Predictors of Survival after Adjuvant Chemotherapy for Colon Cancer
  New England Journal of Medicine, 2001
• Thymidylate Synthase Expression in Patients with Colorectal Carcinoma Using a Polyclonal Thymidylate Synthase Antibody in Comparison to the TS 106 Monoclonal Antibody
  Journal of Histochemistry & Cytochemistry, 2000
• Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients
  British Journal of Cancer, 2000
• Tumor Microsatellite Instability and Clinical Outcome in Young Patients with Colorectal Cancer
  New England Journal of Medicine, 2000
• Immunohistochemical Quantitation of Thymidylate Synthase Expression in Colorectal Cancer Metastases Predicts for Clinical Outcome to Fluorouracil-Based Chemotherapy
  Journal of Clinical Oncology, 1999